Standing With Israel

Want to receive Standing With Israel by email? Sign up here

Scientists in Israel Develop Groundbreaking Approach to Alzheimer’s Treatment

Share:

Israeli scientists at Ben Gurion University of the Negev have proposed a new approach for treating Alzheimer’s disease by targeting its metabolic components.

Several research groups at the university have been working on solutions to address aspects of metabolic function and to identify how its dysfunction relates to immune response, inflammation and ultimately cell death.

One recent proposal targets the voltage-dependent anion channel-1 (VDAC1), which is the mitochondrial gatekeeper, controlling mitochondrial activity and cell death.

Life Sciences Prof. Varda Shoshan-Barmatz leads a research team which showed that an increase in the amount of VDAC1 protein in the cell leads to cell death and an immune response.

While protein VDAC1’s role in heart disease, intestinal disease and autoimmune diseases was already known, the team discovered that the protein was also present, in large amounts, in the brain of a mouse model for Alzheimer’s disease.

Shoshan-Barmatz developed a small molecule, VBIT-4, that binds to VDAC1 and able to prevent many of the pathophysiological changes associated with Alzheimer’s.

VBIT-4 is able to pass the blood-brain barrier and was able to prevent neuronal cell death, neuro-inflammation and neuro-metabolic dysfunctions associated with Alzheimer’s disease.

Another research group at Ben Gurion is also working on a metabolic aspect of Alzheimer’s.

Colbert brain zoneDr. Debra Toiber is leading research focused on a protein called SIRT6, which helps maintain proper the function of mitochondria. Its absence leads to many characteristics of neurodegenerative diseases including Alzheimer’s.

In the past few years, Israeli researchers have been at the forefront of many recent findings on Alzheimer’s disease and have released a variety of Alzheimer’s studies and proposed treatments.

Alzheimer’s disease is a form of dementia. The disease was first described by the German researchers Alois Alzheimer and Emil Kraepelin. The number of people affected by the disease is projected to reach 135 million by 2050. {eoa}

This article originally appeared on ALL ISRAEL NEWS and is reposted with permission.

For more on brain health, you can purchase Dr. Don Colbert’s book, “Dr. Colbert’s Healthy Brain Zone” here.

Bring Charisma magazine home with a subscription today!

The All Israel News Staff is a team of journalists in Israel.

+ posts
Share:

Related topics:

See an error in this article?

Send us a correction

To contact us or to submit an article

Click and play our featured shows

Jesse Duplantis: ‘Poverty Is a Curse’

There is a wide range of opinions and emotions within the Christian community when it comes to blessing, prosperity and poverty. Interpretations of various verses in the Bible as well as analyzing the words of Jesus and how He lived...

Cahn Talks Mental Health Amid MacArthur Backlash

Pastor John Macarthur is facing backlash from the Christian community after his statements that PTSD is nothing more than grief. “If you understand, take PTSD, for example, what that really is, is grief. You are fighting a war you lost....

Hillsong Settles Assault Case Against Former Staff Member

Hillsong has settled an assault case against one of their former staff members, Jason Mays, in the assault against Anna Crenshaw.   According to ChurchLeaders, the Australian-based megachurch has settled with a former Hillsong college student, Crenshaw. She filed a...

University Protests ‘An Externally Funded and Organized Effort’

https://www.youtube.com/watch?v=iyNFI-kXpZ4 JERUSALEM, Israel – Within just a few weeks, anti-Israel protests have expanded to occupy U.S. campuses coast to coast. Given the overall coordination, officials are questioning whether these demonstrations go beyond a spontaneous student movement to a more well-funded outside...

1 2 3 4 5 6 7 8 97 98 99 100
Scroll to Top